Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.

@article{Eary1998QuantitativeP,
  title={Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.},
  author={J. F. Eary and Ernest U. Conrad and James D. Bruckner and A Folpe and K J Hunt and David A. Mankoff and Andrew Howlett},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={1998},
  volume={4 5},
  pages={1215-20}
}
The purpose of this study was to determine the relationship between sarcoma tumor grade and the quantitative tumor metabolism value for [F-18]fluorodeoxyglucose (FDG) determined by positron emission tomography (PET) imaging. Seventy patients with bone or soft-tissue sarcomas underwent PET scanning with quantitative determination of tumor FDG metabolic rate (MRFDG) before treatment. MRFDG (micromol/g/min) for each tumor was compared with National Cancer Institute tumor grade, S-phase percentage… CONTINUE READING